Mobile Phone-based Video Education on Diabetes

November 28, 2021 updated by: Özlem Tekir, Balikesir University

Effectiveness of Mobile Phone-based Distance Video Education in Individuals With Type 2 Diabetes: A Randomized Controlled Trial

This study aimed to examine the effect of mobile phone-based distance video education given to individuals with type 2 diabetes on metabolic variables and cognitive-social factors. This study is a randomized controlled trial.

Study Overview

Detailed Description

MATERIALS AND METHODS:

This study is a randomized controlled trial.

Participants:

The population of the study consisted of individuals with type 2 diabetes who presented to hospital diabetes outpatient clinic between July 2018 and January 2019, and the study sample, on the other hand, included a total of 100 individuals with type 2 diabetes who met the inclusion criteria and agreed to participate in the study. The study was completed with a total of 93 subjects, including 46 in the intervention group (n = 46) and 47 in the control group (n= 47). A Diagnosis and Follow-up Form for Individuals with Diabetes (socio-demographic characteristics, diabetes-related characteristics, metabolic values), which was prepared by the researcher in line with the literature, and the Turkish Multidimensional Diabetes Questionnaire (T-MDDQ) were used to collect the data.

Preparation and content of the education material:

The education material was based on four different guidelines, namely, educator's guidelines for adults with diabetes; the diagnosis, treatment, and follow-up guidelines for diabetes mellitus and its complications; diabetes diagnosis and treatment guidelines; and international education guidelines for diabetes health professionals. The diabetes education videos prepared and presented by the researcher in line with these resources were sent to the participants' smartphones in parts. The educational content consisted of 8 sections: what is diabetes? (basic concepts, symptoms, diagnostic criteria, importance), medical nutrition therapy in diabetes, exercise therapy in diabetes, medical treatment in diabetes, acute complications of diabetes, chronic complications of diabetes, foot problems in diabetes, life with diabetes, and diabetes management under special cases.

Data collection process:

The intervention group: In the first meeting, the individuals in the intervention group were informed about the video-based diabetes education and how they would get the videos, and data collection forms were administered. The blood analysis results (HbA1c, glucose, total cholesterol, HDL, LDL, triglyceride) taken on the same day during outpatient clinic follow-ups were recorded. After the administration of the forms, blood pressure, height, and weight measurements were made, and the first interview was completed. Following the first interview, diabetes education videos created previously were sent to the mobile phones of the individuals in two episodes a week fashion. Video submission was completed in a total of four weeks. In the second interview, three months after the video submission had been completed, data collection forms were re-administered to the individuals, and blood analysis results were recorded. The interview was completed after measuring their blood pressure and weight. During the period between the first and second interviews, the individuals continued to receive routine outpatient follow-ups.

The control group: In the first interview, the individuals with diabetes in the control group were given information about the study, and then data collection forms were administered. The blood analysis results (HbA1c, glucose, total cholesterol, HDL, LDL, triglyceride) taken on the same day during outpatient clinic follow-ups were recorded. The first interview was completed after blood pressure, height, and weight measurements were made. Later, individuals continued to receive routine outpatient follow-ups without any other procedures. In the second interview held three months later, data collection forms were re-administered, and blood analysis results, blood pressure, and weight measurements were recorded. At the end of the second interview, diabetes education videos were sent to the individuals in the control group, too, and they were provided with the same education.

Data analysis:

The statistical package for social science (SPSS) version 25.0 (IBM Corp. Armonk, NY) was used to analyze the data. P<.05 was accepted statistically significant. In descriptive statistics, mean, ± standard deviation, median, minimum and maximum values, and percentages were used, and in nonparametric tests, Mann-Whitney U, Pearson's chi-square, Fisher's exact test, McNemar's test, Wilcoxon signed ranks test, and Spearman's rho measurements were employed.

Study Type

Interventional

Enrollment (Actual)

93

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Altıeylül
      • Balıkesir, Altıeylül, Turkey, 10100
        • Balıkesir University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Having a diagnosis of Type 2 diabetes mellitus for at least 6 months.
  • Being between the ages of 18-65.
  • Being on oral antidiabetic and/or insulin therapy.
  • Having a mobile phone capable of receiving and playing video messages.
  • Volunteering to participate in the study.
  • Sensory losses such as hearing and speech that will prevent communication

Exclusion Criteria:

  • Being under 18 years of age
  • Not having a mobile phone capable of receiving and playing video messages
  • Not willing to participate in the study
  • Having sensory loss such as hearing and speaking that prevents communication

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: HEALTH_SERVICES_RESEARCH
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Intervention Group
individuals with odd sequence numbers were assigned to the intervention group (n=46)
Following the first interview, diabetes education videos created previously were sent to the mobile phones of the individuals in two episodes a week fashion. Video submission was completed in a total of four weeks. In the second interview, three months after the video submission had been completed, data collection forms were re-administered to the individuals, and blood analysis results were recorded.
NO_INTERVENTION: Control Group
those with even numbers to the control group (n=47).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Turkish Multidimensional Diabetes Questionnaire
Time Frame: pre-test (baseline), post-test (3 months follow-up)

Change from baseline diabetes-related cognitive and social factors at 3 months. Responses were on a Likert-type scale (0-not at all significant).

not, 100-very important) is marked. High school scores perceived self-efficacy and outcome indicates high expectations.

pre-test (baseline), post-test (3 months follow-up)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
HbA1C
Time Frame: pre-test (baseline), post-test (3 months follow-up)
HbA1C-change from baseline HbA1C at 3 months
pre-test (baseline), post-test (3 months follow-up)
glucose
Time Frame: pre-test (baseline), post-test (3 months follow-up)
glucose -change from baseline glucose at 3 months
pre-test (baseline), post-test (3 months follow-up)
total cholesterol
Time Frame: pre-test (baseline), post-test (3 months follow-up)
total cholesterol -change from baseline total cholesterol at 3 months
pre-test (baseline), post-test (3 months follow-up)
HDL
Time Frame: pre-test (baseline), post-test (3 months follow-up)
HDL -change from baseline HDL at 3 months
pre-test (baseline), post-test (3 months follow-up)
LDL
Time Frame: pre-test (baseline), post-test (3 months follow-up)
LDL -change from baseline LDL at 3 months
pre-test (baseline), post-test (3 months follow-up)
triglyceride
Time Frame: pre-test (baseline), post-test (3 months follow-up)
triglyceride -change from baseline triglyceride at 3 months
pre-test (baseline), post-test (3 months follow-up)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ali Kamil Bayraktar, Balikesir University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 1, 2018

Primary Completion (ACTUAL)

January 31, 2019

Study Completion (ACTUAL)

July 1, 2019

Study Registration Dates

First Submitted

October 23, 2021

First Submitted That Met QC Criteria

November 28, 2021

First Posted (ACTUAL)

December 9, 2021

Study Record Updates

Last Update Posted (ACTUAL)

December 9, 2021

Last Update Submitted That Met QC Criteria

November 28, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus, Type 2

Clinical Trials on mobile phone-based distance video education group

Subscribe